Virologic response to bictegravir/emtricitabine/tenofovir alafenamide in people with advanced HIV-1 disease: A propensity-weighted multicentre cohort study

International Journal of Antimicrobial Agents · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles